Reports preliminary Q2 revenue $63.7M, consensus $62.91M. Adjusted EBITDA is expected to be $20.9M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DH:
- Definitive Healthcare launches redesigned mobile app to enhance access to healthcare commercial intelligence
- Definitive Healthcare Corp. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Definitive Healthcare Wins 2024 Databricks Healthcare and Life Sciences Partner of the Year Award
- Definitive Healthcare Publishes 2023 Sustainability Report